Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 3, 2009
Carbohydrate deficient transferrin and forensic medicineJoris R Delanghe, Marc L De Buyzere
Advances in Experimental Medicine and Biology|May 11, 2021
Genetic Polymorphisms in the Host and COVID-19 InfectionJoris R Delanghe, Marc L De Buyzere, Marijn M Speeckaert
Current Pharmaceutical Design|December 8, 2004
Hypertension in peripheral arterial diseaseDenis L Clement, Marc L De Buyzere, Daniel A Duprez
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 27, 2012
Non-oxidative ethanol metabolites as a measure of alcohol intakeThomas M Maenhout, Marc L De Buyzere, Joris R Delanghe
Expert Opinion on Investigational Drugs|January 9, 2003
Developing pharmaceutical treatments for peripheral artery diseaseDaniel A Duprez, Marc L De Buyzere, Alan T Hirsch
Atherosclerosis|April 22, 2011
Haptoglobin polymorphism: a key factor in the proatherogenic role of B cells?Joris R Delanghe, Michel R Langlois, Marc L De Buyzere
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 8, 2012
Carbohydrate deficient transferrin in a driver's license regranting programThomas M Maenhout, Guido Baten, Marc L De Buyzere, et al.
Acta Clinica Belgica|November 8, 2021
On the protein content of kidney stones: an explorative studyMieke Steenbeke, Marc L De Buyzere, Marijn M Speeckaert, et al.
Clinical Chemistry and Laboratory Medicine|March 12, 2011
Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturiaAn-Sofie C Decavele, Lien Dhondt, Marc L De Buyzere, et al.
Clinical Chemistry|July 24, 2007
Vitamin C deficiency and scurvy are not only a dietary problem but are codetermined by the haptoglobin polymorphismJoris R Delanghe, Michel R Langlois, Marc L De Buyzere, et al.
Pageof 9